Skip to content
← Full study record

NCT01444417 · OUTCOME

Percentage of Participants Who Received Rescue Medication During the Treatment Period

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients · Source last updated 2017-02-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
24 weeks

What was measured

Rescue medication is any medication (other than excluded medications) that is intended to increase platelet counts or prevent bleeding.

Analysis population: Efficacy analysis set

Groups in this outcome

Placebo

Participants received weekly subcutaneous placebo for 24 weeks.

Romiplostim

Participants received once weekly subcutaneous romiplostim for 24 weeks at a starting dose of 1 µg/kg; weekly dose increases continued in increments of 1 µg/kg/week to a maximum dose of 10 µg/kg in an attempt to reach a target platelet count of ≥ 50 x 10\^9/L.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Placebo20
Romiplostim42

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Placebo45.0Not reported23.168.5Not reported
Romiplostim40.5Not reported25.656.7Not reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Lower Limit
    0.277
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    2.391
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    p Value
    0.7103
    param Type
    Odds Ratio (OR)
    param Value
    0.813
    statistical Comment
    P-value from Cochran-Mantel-Haenszel test stratified by baseline age group
    statistical Method
    Cochran-Mantel-Haenszel
Complete source fields
analyses
  1. ci Lower Limit
    0.277
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    2.391
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    p Value
    0.7103
    param Type
    Odds Ratio (OR)
    param Value
    0.813
    statistical Comment
    P-value from Cochran-Mantel-Haenszel test stratified by baseline age group
    statistical Method
    Cochran-Mantel-Haenszel
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        23.1
        upper Limit
        68.5
        value
        45.0
      2. group Id
        OG001
        lower Limit
        25.6
        upper Limit
        56.7
        value
        40.5
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    2. group Id
      OG001
      value
      42
    units
    Participants
description
Rescue medication is any medication (other than excluded medications) that is intended to increase platelet counts or prevent bleeding.
dispersion Type
95% Confidence Interval
groups
  1. description
    Participants received weekly subcutaneous placebo for 24 weeks.
    id
    OG000
    title
    Placebo
  2. description
    Participants received once weekly subcutaneous romiplostim for 24 weeks at a starting dose of 1 µg/kg; weekly dose increases continued in increments of 1 µg/kg/week to a maximum dose of 10 µg/kg in an attempt to reach a target platelet count of ≥ 50 x 10\^9/L.
    id
    OG001
    title
    Romiplostim
param Type
NUMBER
population Description
Efficacy analysis set
reporting Status
POSTED
time Frame
24 weeks
title
Percentage of Participants Who Received Rescue Medication During the Treatment Period
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice